Your browser doesn't support javascript.
loading
Harnessing consumer wearable digital biomarkers for individualized recognition of postpartum depression using the All of Us Research Program dataset.
Hurwitz, Eric; Butzin-Dozier, Zachary; Master, Hiral; O'Neil, Shawn T; Walden, Anita; Holko, Michelle; Patel, Rena C; Haendel, Melissa A.
  • Hurwitz E; Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Butzin-Dozier Z; Wright Center for Clinical and Translational Research, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.
  • Master H; School of Public Health, University of California, Berkeley, Berkeley, CA, USA.
  • O'Neil ST; Vanderbilt Institute of Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Walden A; Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Holko M; Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Patel RC; International Computer Science Institute, Berkeley, CA, USA.
  • Haendel MA; Department of Infectious Disease, University of Alabama at Birmingham, Birmingham, AL, USA.
medRxiv ; 2023 Oct 14.
Article en En | MEDLINE | ID: mdl-37873471
ABSTRACT
Postpartum depression (PPD), afflicting one in seven women, poses a major challenge in maternal health. Existing approaches to detect PPD heavily depend on in-person postpartum visits, leading to cases of the condition being overlooked and untreated. We explored the potential of consumer wearable-derived digital biomarkers for PPD recognition to address this gap. Our study demonstrated that intra-individual machine learning (ML) models developed using these digital biomarkers can discern between pre-pregnancy, pregnancy, postpartum without depression, and postpartum with depression time periods (i.e., PPD diagnosis). When evaluating variable importance, calories burned from the basal metabolic rate (calories BMR) emerged as the digital biomarker most predictive of PPD. To confirm the specificity of our method, we demonstrated that models developed in women without PPD could not accurately classify the PPD-equivalent phase. Prior depression history did not alter model efficacy for PPD recognition. Furthermore, the individualized models demonstrated superior performance compared to a conventional cohort-based model for the detection of PPD, underscoring the effectiveness of our individualized ML approach. This work establishes consumer wearables as a promising avenue for PPD identification. More importantly, it also emphasizes the utility of individualized ML model methodology, potentially transforming early disease detection strategies.